SCHEMBL2627474

SCHEMBL2627474

CCOP1OCCCO1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2889522 0.95
SCHEMBL9318162 0.79
SCHEMBL10259225 0.74
SCHEMBL11656260 0.73 ALDH1A1 (0.36)
SCHEMBL11651234 0.73 ALDH1A1 (0.36)
SCHEMBL13948852 0.73
SCHEMBL9399037 0.72
SCHEMBL4947415 0.72
SCHEMBL11654525 0.70 ALDH1A1 (0.31)
SCHEMBL4925317 0.70

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 48 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112262487-A Method for manufacturing lithium ion battery 日产自动车株式会社 2021-01-22 CN disclosed
EP-2995604-B1 PHENOL DERIVATIVE AND PREPARATION METHOD AND USE IN MEDICINE THEREOF SICHUAN HAISCO PHARMACEUTICAL CO LTD (CN) 2019-07-10 EP disclosed
US-20180153912-A1 Prodrugs of 2,4-Pyrimidinediamine Compounds and Their Uses RIGEL PHARMACEUTICALS, INC. (US) 2018-06-07 US disclosed
US-20170291909-A1 Prodrugs of 2,4-Pyrimidinediamine Compounds and Their Uses RIGEL PHARMACEUTICALS, INC. (US) 2017-10-12 US disclosed
US-9737554-B2 Prodrugs of 2,4-pyrimidinediamine compounds and their uses RIGEL PHARMACEUTICALS, INC. (US) 2017-08-22 US disclosed
US-9532998-B2 Prodrugs of 2,4-pyrimidinediamine compounds and their uses RIGEL PHARMACEUTICALS, INC. (US) 2017-01-03 US disclosed
US-20160367575-A1 Prodrugs of 2,4-Pyrimidinediamine Compounds and Their Uses RIGEL PHARMACEUTICALS, INC. (US) 2016-12-22 US disclosed
US-20160136191-A1 Prodrugs of 2,4-Pyrimidinediamine Compounds and Their Uses RIGEL PHARMACEUTICALS, INC. (US) 2016-05-19 US disclosed
US-9283238-B2 Prodrugs of 2,4-pyrimidinediamine compounds and their uses RIGEL PHARMACEUTICALS, INC. (US) 2016-03-15 US disclosed
US-9266912-B2 Prodrugs of 2,4-pyrimidinediamine compounds and their uses RIGEL PHARMACEUTICALS, INC. (US) 2016-02-23 US disclosed
US-7563892-B1 Prodrugs of 2,4 pyrimidinediamine compounds and their uses RIGEL PHARMACEUTICALS, INC. (US) 2009-07-21 US disclosed
US-7538108-B2 Prodrugs of 2,4-pyrimidinediamine compounds and their uses RIGEL PHARMACEUTICALS, INC. (US) 2009-05-26 US disclosed
US-20090124580-A1 Autoimmune diseases; water solubility of prodrug can be tailored to improve bioavailability using substution at amine groups; inhibitors of degranulation of immune cells; inhibit/activate Fc receptor signaling cascades RIGEL PHARMACEUTICALS, INC. 2009-05-14 US disclosed
US-20090048214-A1 Methods for Treating Renal Tumors Using 2, 4-Pyrimidinediamine Drug and Prodrug Compounds RIGEL PHARMACEUTICALS, INC (US) 2009-02-19 US disclosed
US-7449458-B2 Autoimmune diseases; water solubility of prodrug can be tailored to improve bioavailability using substution at amine groups; inhibitors of degranulation of immune cells; inhibit/activate Fc receptor signaling cascades; tyrosine kinase Syk kinase inhibitor; collagen-induced platelet activation inhibitor RIGEL PHARMACEUTICALS, INC. (US) 2008-11-11 US disclosed
US-20080096844-A1 Novel inhibitors of chymase JANSSEN PHARMACEUTICA, N.V. (BE) 2008-04-24 US disclosed
US-4147653-A Storable mixtures containing aromatic isocyanatosulphonic acids BAYER AKTIENGESELLSCHAFT (DE) 1979-04-03 US disclosed
US-4082897-A SELF-POLYMERIZATION OF PENTAERYTHRITOL PHOSPHITE BORG-WARNER CORPORATION (US) 1978-04-04 US disclosed
US-4071583-A REACTING ALCOHOLS WITH CYCLIC PHOSPHITES; &amp;OLYPHOSPHONATES; ADHESIVES, FIRE RETARDANTS BORG-WARNER CORPORATION (US) 1978-01-31 US disclosed
US-3978166-A FIRE RETARDANT, GLASS ADHESIVE BORG-WARNER CORPORATION (US) 1976-08-31 US disclosed